Prior Auth Required

0152U - plasma, untargeted next-generation sequencing, report for significant positive pathogens

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Serviceplasma, untargeted next-generation sequencing, report for significant positive pathogens
Procedure / Service Description

hereditary breast and ovarian cancer) mRNA sequence analysis (List separately in addition to - 0142U target reported as detected or not detected Infectious disease (bacteria, fungi, parasites, and DNA viruses), microbial cell-free DNA, 0152U plasma, untargeted next-generation sequencing, report for significant positive pathogens Oncology (breast), mRNA, gene expression profiling by next-generation sequencing of 101 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a triple

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.